Loading image...

Early Detection is Critical

Detecting oral abnormalities early leads to more treatment options, potentially less invasive or radical treatments and better patient outcomes.

Introducing the VELscope® Vx Enhanced Oral Assessment System, which centers on a wireless, handheld scope that applies tissue fluorescence visualization to identify oral mucosal abnormalities early - often months or even years before they can be identified with the unassisted eye.

Cleared by the FDA, and approved by Health Canada, and the World Health Organization, the award-winning VELscope® Vx is the world's most widely used adjunctive device for the discovery of:

  • Viral, fungal and bacterial infections;
  • Inflammation from a variety of causes (lichen planus and lichenoid reactions, allergy to amalgam fillings, etc.);
  • Squamous papillomas;
  • Salivary gland tumors;
  • Cancer and pre-cancer;
  • Other oral mucosal conditions...

Learn what Dr. Gordon J. Christensen, one of the most respected minds in dentistry, has to say about head and neck exams and the value of adjunctive devices.

More than 25 million VELscope® Vx examinations have been performed by over 12,000 dental practitioners in 23 countries. The technology is also backed by more clinical studies than any other adjunctive device for tissue fluorescence visualization.

To learn more, contact your preferred dental supply representative. You can also register for a free live webinar by calling 888.541.4614 (N. America) or 604.434.4614, extension 268.

Awards
April is Oral Cancer Awareness Month | Get Involved

As seen on...